Mon Mar 18 19:36:05 EDT 2024
/jet/home/zyou2/.conda/envs/biosum/lib/python3.9/site-packages/transformers/utils/generic.py:441: UserWarning: torch.utils._pytree._register_pytree_node is deprecated. Please use torch.utils._pytree.register_pytree_node instead.
  _torch_pytree._register_pytree_node(
/jet/home/zyou2/.conda/envs/biosum/lib/python3.9/site-packages/transformers/utils/generic.py:309: UserWarning: torch.utils._pytree._register_pytree_node is deprecated. Please use torch.utils._pytree.register_pytree_node instead.
  _torch_pytree._register_pytree_node(
/jet/home/zyou2/.conda/envs/biosum/lib/python3.9/site-packages/transformers/utils/generic.py:309: UserWarning: torch.utils._pytree._register_pytree_node is deprecated. Please use torch.utils._pytree.register_pytree_node instead.
  _torch_pytree._register_pytree_node(
['abbreviations', 'access to data', 'accme accreditation', 'acknowledgments', 'aetiology', 'anamnesis', 'anamnesis and clinical findings', 'antecedents', 'approach to the problem', 'article title and bibliographic information', 'audience', 'availability', 'availability and supplementary information', 'background', 'background and context', 'background and importance', 'background and introduction', 'background and motivation', 'background and overview', 'background and significance', 'background content', 'background context', 'background data', 'background information', 'background of the study', 'background to the debate', 'background/introduction', 'background/rationale', 'background/significance', 'backgrounds', 'basic remarks', 'basics', 'basis', 'citation', 'clinical trial', 'clinical trial information', 'clinical trial number', 'clinical trial registration', 'clinical trial registration information', 'clinical trial registration number', 'clinical trial registration url', 'clinical trial registration- url', 'clinical trial registry', 'clinical trial registry number', 'clinical trials identifier', 'clinical trials registration', 'clinical trials registration number', 'clinical trials registry', 'condition', 'conflict of interest', 'conflict-of-interest statement', 'contact', 'contacts', 'content', 'contents', 'context', 'context & background', 'context and rationale', 'context of case', 'context/background', 'current knowledge', 'current knowledge and key points', 'current situation', 'current situation and salient points', 'declaration of interest', 'definition', 'definitions', 'descriptor', 'descriptors', 'developer and funding', 'disclosure', 'disease overview', 'electronic supplementary material', 'endorsement', 'enhanced version', 'epidemiology', 'ethics and dissemination', 'ethno pharmacological relevance', 'ethnopharmacological evidence', 'ethnopharmacological importance', 'ethnopharmacological relevance', 'ethnopharmacological significance', 'ethnopharmacology', 'ethnopharmacology relevance', 'etiology', 'financial disclosure', 'financial disclosure(s)', 'financial disclosures', 'foundation', 'funding', 'funding source', 'funding sources', 'genetics', 'global importance', 'health political background', 'historical aspects', 'historical background', 'historical overview', 'historical perspective', 'history and admission diagnosis', 'importance of the field', 'importance to the field', 'incidence', 'infection', 'instruction', 'intention, goal, scope, background', 'intro', 'introduction', 'introduction & background', 'introduction and background', 'introduction and development', 'introduction and material', 'introduction or background', 'introduction/background', 'introductions', 'jel classification', 'jel codes', 'justification', 'key words', 'keywords', 'linked article', 'linked articles', 'mini summary', 'motivation', 'motivations', 'open peer review', 'organizing constructs', 'overview', 'overview of literature', 'physical properties', 'practical relevance', 'preface', 'preliminary studies', 'prevalence', 'primary argument', 'primary funding source', 'principle', 'principles', 'protocol registration', 'rational', 'rationale', 'rationale and background', 'reason for performing study', 'reason for study', 'reasons for performing study', 'reasons for performing the study', 'recent advances', 'recent developments', 'reference/citation', 'registration', 'registration details', 'registration id in irct', 'registration number', 'review registration', 'scientific background', 'scope and background', 'scope of the problem', 'situation', 'source of funding', 'sponsor', 'sponsors', 'sponsorship', 'sponsorships', 'starting point', 'state of art', 'state of knowledge', 'state of the art', 'statement of problem', 'statement of problem and rationale', 'statement of problems', 'statement of the problem', 'statements of the problem', 'study background', 'study funding', 'study funding/competing interest', 'study funding/competing interest(s)', 'study funding/competing interests', 'study registration', 'summary and background', 'summary and background data', 'summary background', 'summary background data', 'summary of background', 'summary of background data', 'summary of background information', 'summary of the background data', 'supplemental material', 'supplementary information', 'support', 'systematic review registration', 'target audience', 'theoretical background', 'theoretical considerations', 'theories', 'theory', 'title', 'trial number', 'trial register', 'trial registration', 'trial registration isrctn', 'trial registration no', 'trial registration number', 'trial registration numbers', 'trial registrations', 'trial registry', 'trials registration', 'useful websites', 'video abstract available', 'what is already known', 'what is already known about this subject', 'what is known', 'what is known already', 'what is known and background', 'what is known and what this paper adds', 'what will the reader gain']
['actions taken', 'advances in knowledge', 'advances in knowledge and implications for patient care', 'advantages', 'answer', 'application', 'application to clinical practice', 'application/conclusions', 'applications', 'applications/conclusion', 'applications/conclusions', 'areas timely for developing research', 'areas to develop research', "author's conclusions", "authors' conclusion", "authors' conclusions", 'best practices', 'bias, confounding and other reasons for caution', 'bottom line', 'capsule summary', 'challenges', 'challenges and lessons learned', 'clinical advantages', 'clinical implication', 'clinical implications', 'clinical importance', 'clinical potential', 'clinical recommendations', 'clinical rehabilitation impact', 'clinical relevance', 'clinical significance', 'clinical value', 'comment', 'commentaries', 'commentary', 'comments', 'comments and conclusion', 'comments and conclusions', 'comparison with existing method', 'comparison with existing method(s)', 'concluding remarks', 'concluding statement', 'conclusion', 'conclusion & clinical relevance', 'conclusion & discussion', 'conclusion & implications', 'conclusion & inferences', 'conclusion and clinical implications', 'conclusion and clinical importance', 'conclusion and clinical rehabilitation impact', 'conclusion and clinical relevance', 'conclusion and clinical significance', 'conclusion and discussion', 'conclusion and general significance', 'conclusion and impact', 'conclusion and implication', 'conclusion and implications', 'conclusion and implications for practice', 'conclusion and message', 'conclusion and outlook', 'conclusion and perspective', 'conclusion and perspectives', 'conclusion and potential relevance', 'conclusion and practice implications', 'conclusion and recommendation', 'conclusion and recommendations', 'conclusion and relevance', 'conclusion and relevance to clinical practice', 'conclusion and scientific significance', 'conclusion and significance', 'conclusion(s)', 'conclusion-discussion', 'conclusion/clinical relevance', 'conclusion/discussion', 'conclusion/hypothesis', 'conclusion/implications', 'conclusion/implications for practice', 'conclusion/interpretation', 'conclusion/recommendation', 'conclusion/recommendations', 'conclusion/relevance', 'conclusion/significance', 'conclusions', 'conclusions & clinical importance', 'conclusions & clinical relevance', 'conclusions & implication', 'conclusions & implications', 'conclusions & implications for nursing', 'conclusions & inferences', 'conclusions & interpretation', 'conclusions & recommendations', 'conclusions & significance', 'conclusions / implications for practice', 'conclusions and clinical implications', 'conclusions and clinical importance', 'conclusions and clinical relevance', 'conclusions and clinical significance', 'conclusions and discussion', 'conclusions and general significance', 'conclusions and impact', 'conclusions and implication', 'conclusions and implications', 'conclusions and implications for cancer survivors', 'conclusions and implications for nursing management', 'conclusions and implications for practice', 'conclusions and implications of key findings', 'conclusions and inferences', 'conclusions and interpretation', 'conclusions and limitations', 'conclusions and outlook', 'conclusions and perspectives', 'conclusions and potential relevance', 'conclusions and practical implications', 'conclusions and practice implications', 'conclusions and recommendations', 'conclusions and relevance', 'conclusions and relevance to clinical practice', 'conclusions and scientific significance', 'conclusions and significance', 'conclusions significance', 'conclusions(s)', 'conclusions, significance and impact of the study', 'conclusions/ significance', 'conclusions/applications', 'conclusions/clinical relevance', 'conclusions/discussion', 'conclusions/findings', 'conclusions/implications', 'conclusions/implications for practice', 'conclusions/importance', 'conclusions/interpretation', 'conclusions/interpretations', 'conclusions/lessons learned', 'conclusions/level of evidence', 'conclusions/practice implications', 'conclusions/recommendations', 'conclusions/relevance', 'conclusions/significance', 'conclusions/significances', 'conclusions/summary', 'condensation', 'condensed abstract', 'conditions', 'consequence', 'consequences', 'consideration', 'considerations', 'contextual issues', 'critical issues and future directions', 'current & future development', 'data synthesis and conclusion', 'data synthesis and conclusions', 'development and conclusion', 'development and conclusions', 'developments', 'disclaimer', 'discussion', 'discussion & conclusion', 'discussion & summary', 'discussion - conclusion', 'discussion and conclusion', 'discussion and conclusions', 'discussion and implications', 'discussion and implications for practice', 'discussion and limitations', 'discussion and recommendations', 'discussion and summary', 'discussion, conclusion', 'discussion-conclusion', 'discussion/conclusion', 'discussion/conclusions', 'discussions', 'discussions and conclusion', 'discussions and conclusions', 'discussions/conclusions', 'emerging areas for developing research', 'epilogue', 'expert opinion', 'final considerations', 'final remarks', 'findings and conclusion', 'findings and conclusions', 'findings and discussion', 'findings and implications', 'findings and practice implications', 'findings/conclusion', 'findings/conclusions', 'future', 'future and projects', 'future directions', 'future perspectives', 'future prospect and projects', 'future prospects', 'future prospects and projects', 'future research', 'future work', 'general significance', 'generalizability to other populations', 'growing points', 'growing points and areas timely for developing research', 'guidelines', 'highlights', 'impact', 'impact for human medicine', 'impact of the study', 'impact on industry', 'impact on research, practice, and policy', 'impact on the industry', 'impact on traffic safety', 'impacts', 'implication', 'implication for cancer survivors', 'implication for further research', 'implication for nursing management', 'implication for nursing practice', 'implication for practice', 'implication of the hypothesis', 'implication statement', 'implications', 'implications and action', 'implications and conclusions', 'implications for cancer survivors', 'implications for case management', 'implications for case management practice', 'implications for clinical practice', 'implications for cm practice', 'implications for further research', 'implications for future research', 'implications for health care provision', 'implications for health care provision and use', 'implications for health policies', 'implications for health policy', 'implications for nurse managers', 'implications for nursing', 'implications for nursing and health policy', 'implications for nursing management', 'implications for nursing practice', 'implications for nursing research', 'implications for policy', 'implications for practice', 'implications for practice/research', 'implications for practise', 'implications for public health', 'implications for public health practice', 'implications for rehabilitation', 'implications for research', 'implications for research and practice', 'implications for research/practice', 'implications of the hypothesis', 'implications statement', 'implications/conclusions', 'in clinical practice', 'in conclusion', 'in practice', 'in summary', 'inference', 'innovation and conclusion', 'innovation and conclusions', 'innovation and implications', 'integrative significance', 'interpretation', 'interpretation & conclusion', 'interpretation & conclusions', 'interpretation and conclusion', 'interpretation and conclusions', 'interpretation/conclusion', 'interpretation/conclusions', 'interpretations', 'interpretations & conclusion', 'interpretations & conclusions', 'interpretations and conclusions', 'key conclusion', 'key conclusion and implications for practice', 'key conclusions', 'key conclusions and implications', 'key conclusions and implications for practice', 'key learning point', 'key learning points', 'key limitations', 'key message', 'key messages', 'key points', 'key practitioner message', 'key questions and answers', 'key recommendations', 'key results and conclusions', 'keys to success', 'knowledge translation', 'learning points', 'lessons', 'lessons and messages', 'lessons learned', 'lessons learnt', 'limitation', 'limitation, reasons for caution', 'limitations', 'limitations and conclusions', 'limitations and reasons for caution', 'limitations of the study', 'limitations, reason for caution', 'limitations, reasons for caution', 'limitations, reasons for cautions', 'limits', 'linking evidence to action', 'main conclusion', 'main conclusions', 'main messages', 'main recommendations', 'main results and conclusions', 'major conclusion', 'major conclusions', 'management of refractory disease', 'message', 'methods and conclusions', 'methods, results and conclusions', 'mini-abstract', 'new information', 'new or unique information provided', 'next steps', 'nursing implications', 'objective and conclusion', 'observation & discussion', 'ongoing issues', 'originality', 'originality/value', 'originality/value of chapter', 'outcomes summary', 'outlook', 'perspective', 'perspectives', 'perspectives and conclusion', 'perspectives and conclusions', 'perspectives and projects', 'place in therapy', 'plain language summary', 'points of consensus', 'policy implications', 'policy points', 'positions', 'potential clinical relevance', 'potential difficulties', 'potential relevance', 'practical application', 'practical applications', 'practical attitude', 'practical implications', 'practical recommendations', 'practice guideline', 'practice implication', 'practice implications', 'practitioner points', 'precis', 'prevention', 'principal conclusion', 'principal conclusions', 'principal findings and conclusions', 'principal findings/conclusions', 'principle conclusions', 'prognosis', 'prospect', 'prospects', 'prospects and projects', 'public health action', 'public health actions', 'public health implications', 'purpose and clinical relevance', 'purposes and clinical relevance', 'qualifying statements', 'recommendation', 'recommendation 1', 'recommendation 2', 'recommendation 3', 'recommendation and outlook', 'recommendation and perspective', 'recommendation and perspectives', 'recommendations', 'recommendations and conclusions', 'recommendations and outlook', 'recommendations and perspective', 'recommendations and perspectives', 'recommendations for clinical practice', 'reflections', 'relevance', 'relevance for clinical practice', 'relevance to clinical or professional practice', 'relevance to clinical practice', 'relevance to practice', 'relevance/impact', 'remarks', 'research implications', 'research implications/limitations', 'research limitations', 'research limitations/implications', 'research recommendations', 'result & conclusion', 'result & conclusions', 'result and conclusion', 'result and conclusions', 'result and discussion', 'result/conclusion', 'results & conclusion', 'results & conclusions', 'results & discussion', 'results & interpretation', 'results and conclusion', 'results and conclusions', 'results and discussion', 'results and discussions', 'results and implications', 'results and interpretation', 'results and interpretations', 'results and limitations', 'results and major conclusion', 'results and recommendations', 'results and significance', 'results and сonclusion', 'results and/or conclusions', 'results, conclusion', 'results-conclusions', 'results/conclusion', 'results/conclusions', 'results/discussion', "reviewer's conclusions", "reviewers' conclusions", 'scientific significance', 'scope and conclusions', 'selected highlights', 'significance', 'significance and impact', 'significance and impact of study', 'significance and impact of the study', 'significance and impacts of the study', 'significance and importance of the study', 'significance and the impact of the study', 'significance of research', 'significance of results', 'significance of the research', 'significance of the study', 'significance/conclusion', 'significance/conclusions', 'significances', 'significant and impact of the study', 'significant outcomes', 'social implications', 'speculation', 'state of art and perspectives', 'state of the art and perspectives', 'statement of conclusions', 'study answer', 'study limitation', 'study limitations', 'summary', 'summary and conclusion', 'summary and conclusions', 'summary and discussion', 'summary answer', 'summary of key points', 'summary of recommendations', 'summary points', 'summary statement', 'summary statements', 'summary/conclusions', 'synopsis', 'take home message', 'take home messages', 'take-home message', 'task force recommendations', 'teaching points', 'the conclusion', 'the future', 'therapeutic implications', 'therapeutic management', 'treatment recommendations', 'tweetable abstract', 'unique information provided', 'vaccination recommendations', 'value/originality', 'viewpoint', 'viewpoint and conclusion', 'viewpoint and conclusions', 'what is new and conclusion', 'what is new and conclusions', 'what this paper adds', 'what this study adds', 'where next', 'wider implication of the findings', 'wider implications of the finding', 'wider implications of the findings']
length of train and val datasets
241
Map:   0%|          | 0/241 [00:00<?, ? examples/s]Map:   2%|▏         | 4/241 [02:24<2:22:21, 36.04s/ examples]Map:   3%|▎         | 8/241 [04:22<2:05:16, 32.26s/ examples]Map:   5%|▍         | 12/241 [06:52<2:12:04, 34.60s/ examples]Map:   7%|▋         | 16/241 [09:08<2:08:57, 34.39s/ examples]Map:   8%|▊         | 20/241 [11:50<2:14:40, 36.56s/ examples]Map:  10%|▉         | 24/241 [14:31<2:16:56, 37.86s/ examples]Map:  12%|█▏        | 28/241 [16:43<2:08:51, 36.30s/ examples]Map:  13%|█▎        | 32/241 [18:59<2:03:52, 35.56s/ examples]Map:  15%|█▍        | 36/241 [21:41<2:06:37, 37.06s/ examples]Map:  17%|█▋        | 40/241 [24:20<2:07:04, 37.93s/ examples]Map:  18%|█▊        | 44/241 [26:44<2:02:37, 37.35s/ examples]Map:  20%|█▉        | 48/241 [29:00<1:56:51, 36.33s/ examples]Map:  22%|██▏       | 52/241 [31:42<1:58:17, 37.55s/ examples]Map:  23%|██▎       | 56/241 [34:23<1:58:24, 38.40s/ examples]Map:  25%|██▍       | 60/241 [36:54<1:55:07, 38.16s/ examples]Map:  27%|██▋       | 64/241 [39:14<1:49:47, 37.21s/ examples]Map:  28%|██▊       | 68/241 [41:48<1:48:26, 37.61s/ examples]Map:  30%|██▉       | 72/241 [44:30<1:48:17, 38.45s/ examples]Map:  32%|███▏      | 76/241 [46:21<1:37:05, 35.30s/ examples]Map:  33%|███▎      | 80/241 [48:51<1:36:23, 35.92s/ examples]Map:  35%|███▍      | 84/241 [51:05<1:32:05, 35.20s/ examples]Map:  37%|███▋      | 88/241 [53:38<1:32:05, 36.11s/ examples]Map:  38%|███▊      | 92/241 [56:04<1:29:58, 36.23s/ examples]Map:  40%|███▉      | 96/241 [58:08<1:23:51, 34.70s/ examples]Map:  41%|████▏     | 100/241 [1:00:28<1:21:45, 34.79s/ examples]Map:  43%|████▎     | 104/241 [1:02:58<1:21:14, 35.58s/ examples]Map:  45%|████▍     | 108/241 [1:05:10<1:17:07, 34.79s/ examples]Map:  46%|████▋     | 112/241 [1:07:51<1:18:23, 36.46s/ examples]Map:  48%|████▊     | 116/241 [1:10:33<1:18:24, 37.63s/ examples]Map:  50%|████▉     | 120/241 [1:12:56<1:14:43, 37.05s/ examples]Map:  51%|█████▏    | 124/241 [1:14:49<1:07:11, 34.45s/ examples]Map:  53%|█████▎    | 128/241 [1:17:31<1:08:19, 36.28s/ examples]Map:  55%|█████▍    | 132/241 [1:19:57<1:05:59, 36.33s/ examples]Map:  56%|█████▋    | 136/241 [1:22:37<1:05:26, 37.39s/ examples]Map:  58%|█████▊    | 140/241 [1:25:07<1:02:59, 37.42s/ examples]Map:  60%|█████▉    | 144/241 [1:27:48<1:01:57, 38.32s/ examples]Map:  61%|██████▏   | 148/241 [1:30:30<1:00:24, 38.97s/ examples]Map:  63%|██████▎   | 152/241 [1:32:58<56:55, 38.38s/ examples]  Map:  65%|██████▍   | 156/241 [1:35:32<54:20, 38.36s/ examples]Map:  66%|██████▋   | 160/241 [1:38:04<51:43, 38.31s/ examples]Map:  68%|██████▊   | 164/241 [1:40:46<50:01, 38.97s/ examples]Map:  70%|██████▉   | 168/241 [1:43:04<45:43, 37.58s/ examples]Map:  71%|███████▏  | 172/241 [1:45:46<44:13, 38.45s/ examples]Map:  73%|███████▎  | 176/241 [1:48:28<42:19, 39.07s/ examples]Map:  75%|███████▍  | 180/241 [1:50:24<36:42, 36.10s/ examples]Map:  76%|███████▋  | 184/241 [1:52:32<33:07, 34.87s/ examples]Map:  78%|███████▊  | 188/241 [1:55:14<32:15, 36.52s/ examples]Map:  80%|███████▉  | 192/241 [1:57:38<29:42, 36.38s/ examples]Map:  81%|████████▏ | 196/241 [2:00:20<28:11, 37.58s/ examples]Map:  83%|████████▎ | 200/241 [2:03:01<26:14, 38.41s/ examples]Map:  85%|████████▍ | 204/241 [2:05:12<22:38, 36.71s/ examples]Map:  86%|████████▋ | 208/241 [2:07:47<20:32, 37.34s/ examples]Map:  88%|████████▊ | 212/241 [2:09:29<16:19, 33.78s/ examples]Map:  90%|████████▉ | 216/241 [2:12:11<14:53, 35.75s/ examples]Map:  91%|█████████▏| 220/241 [2:14:19<12:07, 34.65s/ examples]Map:  93%|█████████▎| 224/241 [2:17:00<10:17, 36.35s/ examples]Map:  95%|█████████▍| 228/241 [2:19:27<07:53, 36.42s/ examples]Map:  96%|█████████▋| 232/241 [2:22:08<05:38, 37.61s/ examples]Map:  98%|█████████▊| 236/241 [2:24:49<03:12, 38.42s/ examples]Map: 100%|█████████▉| 240/241 [2:27:10<00:37, 37.48s/ examples]Map: 100%|██████████| 241/241 [2:27:54<00:00, 38.04s/ examples]Map: 100%|██████████| 241/241 [2:27:54<00:00, 36.82s/ examples]
Malaria is a disease caused by a parasite called Plasmodium vivax, which causes malaria in humans and other animals. The disease is caused by the parasite infecting the liver of the mosquito that feeds on the blood of a human. The parasites infect the liver, where they multiply and divide into two types of parasites called schizonts and hypnozoites. The first stage of the parasite is active, and the second stage is dormant, which is where the parasites die. The second stage of infection is the dormant stage, which can be activated by a mosquito bite, and can lead to a relapse infection. The timing of the first infection and the number of relapses are important factors in determining the transmission of the disease. The time between the first and second infection is also important, but it is not clear how many relapses occur in a person’s life. To investigate this question, Battle et al. developed a mathematical model of how the number and timing of relapsing infections in the liver contribute to the spread of malaria. The model was tested against data from tropical strains of the malaria parasite, and compared with data from humans in the tropics. The results showed that the number, timing and duration of relapse infections are similar to those observed in humans, but that the rate of relapse infections increases with the number or duration of hypnoozoites in the human liver. This suggests that individuals with the most hypozoites are more likely to relapse and be targeted for treatment. The next step is to develop new drugs that can kill the parasites and reduce the number ( or eliminate ) of relapsed infections. This could help to control the disease, and to reduce the transmission rate of malaria in the world.
finished writing
